Wei Leong Chew
Associate Director at Genome Institute of Singapore / Adjunct Assistant Professor at National University of Singapore
Schools
- National University of Singapore
Links
Biography
National University of Singapore
Dr. Wei Leong Chew is GIS Fellow at the Genome Institute of Singapore, A * STAR. His lab develops technologies for making pinpoint changes in the human genome. His work contributed to the first demonstrations of postnatal disease gene correction and transcriptional activation with CRISPR-Cas9. He identified the immunogenic determinants on AAV-CRISPR-Cas9, providing a first insight into the safety profile of CRISPR therapeutics. He co-directs the Molecular Therapeutics Programme - the first DNA and RNA -targeting therapeutics development center in Southeast Asia. Dr. Chew graduated from Duke University for his B.S., and obtained his Ph.D. with Prof. George Church at Harvard Medical School.
Companies
- Adjunct Assistant Professor National University of Singapore (2021)
- Associate Director Genome Institute of Singapore (2021)
- Senior Research Scientist Genome Institute of Singapore (2019)
- Principal Investigator Genome Institute of Singapore (2016)
- GIS Fellow Genome Institute of Singapore (2016 — 2019)
- Graduate student Harvard University (2010 — 2016)
- Research assistant Duke-NUS Graduate Medical School (2009 — 2010)
Education
- Doctor of Philosophy (PhD) Harvard University (2010 — 2016)
- Bachelor of Science (B.S.) Duke University (2006 — 2009)
- A levels Raffles Junior College
Videos
2020 Young Scientist Awards (YSA) Winners
Young Scientist Awards 2020: Dr Chew Wei Leong
Read about executive education
Other experts
Popular Courses
Leading People and Teams
ESMT
Berlin, Germany
Nov 19
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Feb 2, 2025
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Sep 29
Looking for an expert?
Contact us and we'll find the best option for you.